Literature DB >> 11165821

Effects of vehicles and enhancers on transdermal delivery of melatonin.

H J Oh1, Y K Oh, C K Kim.   

Abstract

For a more effective transdermal delivery of melatonin (MT), the effects of vehicles and enhancers on its skin permeation and lag time were evaluated. Skin permeation study was conducted in Franz diffusion cells using excised hairless mouse skins. MT was analyzed by HPLC. As vehicles, ethanol (EtOH), polyethylene glycol 400 (PEG), or propylene glycol (PG) was used alone or mixed with a phosphate buffer. Binary vehicles (EtOH/buffer, PEG/buffer, PG/buffer) showed different effects on the skin permeation of MT and its lag time. Compared with the buffer alone, the PEG/buffer shortened the lag time of MT but reduced its skin permeation. EtOH/buffer significantly increased the flux of MT but prolonged the lag time with the content of EtOH. PG/buffer did not affect the lag time but slightly increased the skin permeation of MT at the higher content of PG (> or =80%). These results indicate that the composition of vehicles exerts significant influence but it per se might have limitation in modulating the transdermal delivery of MT. Next, one tested whether fatty acids could more effectively enhance the skin permeation of MT and shorten its lag time. Given the influence of vehicles on both permeation and lag time, PG was used as a vehicle for fatty acids. The permeation-enhancing effects of saturated fatty acids increased in the following order: C10>C12>C14>C16>C18. The saturated fatty acid, however, did not significantly shorten the lag time regardless of the carbon chain length. Meanwhile, similar to saturated lauric acid (C12), unsaturated oleic acid (C18) dramatically enhanced the skin permeability coefficient of MT more than 950-fold over the effect of PG alone. Moreover, oleic acid showed the shortest lag time (2.1 h). The results suggest that oleic acid in a suitable vehicle could more effectively enhance the skin permeation of MT and shorten its lag time than did the vehicles of various compositions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165821     DOI: 10.1016/s0378-5173(00)00598-6

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations.

Authors:  Adrian P Funke; Roman Schiller; Hans W Motzkus; Clemens Günther; Rainer H Müller; Ralph Lipp
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

2.  Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy.

Authors:  Maria Bernadete Riemma Pierre; Eduardo Ricci; Antonio Cláudio Tedesco; Maria Vitória Lopes Badra Bentley
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

Review 3.  On the role of melatonin in skin physiology and pathology.

Authors:  Andrzej Slominski; Tobias W Fischer; Michal A Zmijewski; Jacobo Wortsman; Igor Semak; Blazej Zbytek; Radomir M Slominski; Desmond J Tobin
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

4.  Transdermal permeation of Kaempferia parviflora methoxyflavones from isopropyl myristate-based vehicles.

Authors:  Sarunya Tuntiyasawasdikul; Ekapol Limpongsa; Napaphak Jaipakdee; Bungorn Sripanidkulchai
Journal:  AAPS PharmSciTech       Date:  2014-05-03       Impact factor: 3.246

5.  Screening of chemical penetration enhancers for transdermal drug delivery using electrical resistance of skin.

Authors:  Vijay Krishna Rachakonda; Krishna Mohan Yerramsetty; Sundararajan V Madihally; Robert L Robinson; Khaled A M Gasem
Journal:  Pharm Res       Date:  2008-08-06       Impact factor: 4.200

Review 6.  Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?

Authors:  Alejandro Romero; Eva Ramos; Francisco López-Muñoz; Cristóbal De Los Ríos; Javier Egea; Emilio Gil-Martín; René Pita; Juan J Torrado; Dolores R Serrano; Antonio Juberias
Journal:  Diseases       Date:  2021-04-10

7.  Transdermal administration of melatonin coupled to cryopass laser treatment as noninvasive therapy for prostate cancer.

Authors:  Laura Terraneo; Paola Bianciardi; Eleonora Virgili; Elena Finati; Michele Samaja; Rita Paroni
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

8.  Design, synthesis of novel lipids as chemical permeation enhancers and development of nanoparticle system for transdermal drug delivery.

Authors:  Srujan Marepally; Cedar H A Boakye; Punit P Shah; Jagan Reddy Etukala; Adithi Vemuri; Mandip Singh
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.